Concepedia
Statistics
Publications
9
Citations
677
H-Index
Active since
2004
Affiliations
Blueprint Medicines (United States)(Current)
Dana-Farber Cancer Institute
The University of Texas MD Anderson Cancer Center
Guy's and St Thomas' NHS Foundation Trust
University of Utah
Oleg Schmidt-Kittler is an author at Blueprint Medicines (United States) specializing in medicine, pharmacology, and allergy.
Top concepts
MedicinePharmacologyAllergyOncologyPathologySclerodermaBiochemistryGene TherapyRheumatologyTumor Biology
Publications per year
2004–2021
A precision therapy against cancers driven by <i>KIT/PDGFRA</i> mutations
Erica N Evans, Alexandra K. Gardino, Joseph L. Kim et al. · Science Translational Medicine · 2017 · 209 citations
Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial
Daniel J. DeAngelo, Deepti Radia, Tracy I. George et al. · Nature Medicine · 2021 · 139 citations · Full text
Immunomagnetic Enrichment, Genomic Characterization, and Prognostic Impact of Circulating Melanoma Cells
Anja Ulmer, Oleg Schmidt-Kittler, Jörg Fischer et al. · Clinical Cancer Research · 2004 · 117 citations · Full text
Acquired On-Target Clinical Resistance Validates FGFR4 as a Driver of Hepatocellular Carcinoma
Megan Hatlen, Oleg Schmidt-Kittler, Cori Ann Sherwin et al. · Cancer Discovery · 2019 · 106 citations
Dissecting isoform selectivity of PI3K inhibitors: the role of non-conserved residues in the catalytic pocket
Mark Frazzetto, Cenk Suphioglu, Jiuxiang Zhu et al. · Biochemical Journal · 2008 · 48 citations · Full text
Catalytic Pocket, Combinatorial Chemistry, Pi3k Inhibitors +21
1–5 of 9